BOTOX® (Botulinum Toxin Type A) as Headache Prophylaxis in Chinese Participants With Chronic Migraine
Status:
Withdrawn
Trial end date:
2021-03-25
Target enrollment:
Participant gender:
Summary
This study will evaluate the efficacy and safety of BOTOX® (Botulinum Toxin Type A) compared
with placebo as headache prophylaxis in Chinese participants with chronic migraine.
Phase:
Phase 3
Details
Lead Sponsor:
Allergan
Treatments:
abobotulinumtoxinA Botulinum Toxins Botulinum Toxins, Type A incobotulinumtoxinA onabotulinumtoxinA